Line 29:
Line 29:
inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
−
Approximately 5-8% of AML cases have inv(16)(p13.1q22) or t(16;16)(p13.1;q22).
+
Approximately 5-8% of AML cases have inv(16)(p13.1q22) or t(16;16)(p13.1;q22) [1].
==Gene Overview==
==Gene Overview==